Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2024-11-19T09:55:34+0000
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
I'm a little template short and blank. I link to void and keep hidden out.
2024-11-19T09:55:34+0000
Trial results from Eli Lilly add to a growing body of evidence that suggests GLP-1 drugs, which include treatments like Lilly’s Mounjaro and Novo Nordisk’s Wegovy, have medical benefits beyond diabetes and weight loss.
2024-04-17T16:11:00+0100
Investors brace for a raft of big earnings and Fed commentary before deciding on the market’s next move.
2024-02-06T14:35:00+0000
Global syringe-filling facilities are struggling to cope with rising demand for anti-obesity drugs, which require injection pens.
2023-12-28T09:10:57+0000
Novo Nordisk shares rose after data showed its weight loss drug led to protective cardiac benefits. IGTV financial analyst @AngelineOng hones in on the global obesity drug race.
2023-11-13T14:14:00+0000